Dec 9 2010 | News
Prometheus
Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced
today the execution of an oncology-focused mutational analysis services agreement
with Bayer Schering Pharma AG, Germany
|
Jun 10 2010 | News
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, and Bayer Schering Pharma AG, a global leading specialty pharmaceuticals company, announced today the closing of a cooperation contract for discovery of novel biomarkers in Endometriosis.
|
Mar 17 2010 | News
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany.
|
Sep 2 2009 | News
CHADDS FORD, Pa. (AP) — The FDA has extended a review of a testosterone drug candidate by three months, the product's maker, Endo Pharmaceuticals Holdings Inc., said Wednesday. The FDA extended its review period to Dec. 2. The review had been scheduled to end Sept. 2.
|
Aug 6 2009 | News
NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Wednesday a U.S. Court backed a ruling that overturned a patent behind Bayer Schering's birth control pill Yasmin. Teva said the U.S. Court of Appeals for the Federal Circuit supported an earlier ruling made by the U.S.
|
Feb 12 2009 | News
FRANKFURT (AP) — German pharmaceutical company Bayer AG said Thursday it will invest euro100 million ($129 million) in a new global research and development center in Beijing over the next five years.
|
May 12 2008 | News
Barr Pharmaceuticals, Inc. recently announced that its subsidiary, Barr Laboratories, Inc., has
|
Nov 13 2006 | Archives
Bayer HealthCare has announced a structural realignment of its global pharmaceutical research and development organization. The company also outlined its future U.S. pharma site plan, and said that New Jersey will be home to its U.S. headquarters for pharmaceuticals.
|